Trial Profile
Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 2
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Ramipril (Primary) ; Valsartan (Primary)
- Indications Hypertension
- Focus Biomarker; Pharmacodynamics
- 08 Mar 2012 New trial record
- 01 Feb 2012 Results published in the Journal of the American Society of Nephrology.
- 01 Feb 2012 Status changed from active, no longer recruiting to completed following publication of study results.